{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:51:04Z","timestamp":1793397064494,"version":"4.5.0"},"reference-count":222,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016471","name":"Agios Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.blre.2023.101165","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:32:16Z","timestamp":1704277936000},"page":"101165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["\u0391lpha-thalassemia: A practical overview"],"prefix":"10.1016","volume":"64","author":[{"given":"Khaled M.","family":"Musallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Domenica","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin H.M.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vip","family":"Viprakasit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali T.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.blre.2023.101165_bb0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027522","article-title":"Molecular genetics of beta-thalassemia: a narrative review","volume":"100","author":"Jaing","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011692","article-title":"World distribution, population genetics, and health burden of the hemoglobinopathies","volume":"2","author":"Williams","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.blre.2023.101165_bb0015","series-title":"Disease control priorities in developing countries","article-title":"Inherited disorders of hemoglobin","author":"Weatherall","year":"2006"},{"issue":"10343","key":"10.1016\/j.blre.2023.101165_bb0020","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","article-title":"Thalassaemia","volume":"399","author":"Kattamis","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011742","article-title":"Clinical manifestations of alpha-thalassemia","volume":"3","author":"Vichinsky","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.blre.2023.101165_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0040","first-page":"11","article-title":"Thalassaemia is a tropical disease","volume":"10","author":"Kotila","year":"2012","journal-title":"Ann Ib Postgrad Med"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0045","first-page":"390","article-title":"Protection against malaria morbidity: near-fixation of the alpha-thalassemia gene in a Nepalese population","volume":"48","author":"Modiano","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF00280500","article-title":"Alpha-thalassemia in Papua New Guinea","volume":"74","author":"Yenchitsomanus","year":"1986","journal-title":"Hum Genet"},{"key":"10.1016\/j.blre.2023.101165_bb0055","first-page":"8","article-title":"Estimating the burden of alpha-thalassaemia in Thailand using a comprehensive prevalence database for Southeast Asia","author":"Hockham","year":"2019","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng1660","article-title":"Negative epistasis between the malaria-protective effects of alpha+\u2212thalassemia and the sickle cell trait","volume":"37","author":"Williams","year":"2005","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2141.2008.07085.x","article-title":"Genetic variation and susceptibility to infection: the red cell and malaria","volume":"141","author":"Weatherall","year":"2008","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030158","article-title":"The effect of alpha+\u2212thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya","volume":"3","author":"Wambua","year":"2006","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(18)30107-8","article-title":"Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study","volume":"5","author":"Ndila","year":"2018","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2005-01-0313","article-title":"Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal plasmodium falciparum malaria on the coast of Kenya","volume":"106","author":"Williams","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0085","first-page":"704","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.blre.2023.101165_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/727905","article-title":"The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders","volume":"2013","author":"Angastiniotis","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.blre.2023.101165_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcmd.2017.09.004","article-title":"Molecular basis of alpha-thalassemia","volume":"70","author":"Farashi","year":"2018","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V73.5.1081.1081","article-title":"A review of the molecular genetics of the human alpha-globin gene cluster","volume":"73","author":"Higgs","year":"1989","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1073\/pnas.79.1.137","article-title":"Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster","volume":"79","author":"Antonarakis","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0110","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2005-03-0948","article-title":"A newly discovered human alpha-globin gene","volume":"106","author":"Goh","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/biom13040683","article-title":"Ligand-based regulation of dynamics and reactivity of hemoproteins","volume":"13","author":"Turilli-Ghisolfi","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.exphem.2004.11.007","article-title":"Control of globin gene expression during development and erythroid differentiation","volume":"33","author":"Stamatoyannopoulos","year":"2005","journal-title":"Exp Hematol"},{"issue":"15","key":"10.1016\/j.blre.2023.101165_bb0125","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2010-11-316893","article-title":"Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities","volume":"117","author":"Wilber","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2023.101165_bb0130","series-title":"StatPearls [internet]","article-title":"Laboratory evaluation of alpha thalassemia","author":"Motiani","year":"2023"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.hoc.2022.12.001","article-title":"Molecular basis and genetic modifiers of thalassemia","volume":"37","author":"Tesio","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2023.101165_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-5-13","article-title":"Alpha-thalassaemia","volume":"5","author":"Harteveld","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/GIM.0b013e3181fcb468","article-title":"Alpha-thalassemia","volume":"13","author":"Galanello","year":"2011","journal-title":"Genet Med"},{"issue":"32","key":"10.1016\/j.blre.2023.101165_bb0150","doi-asserted-by":"crossref","first-page":"15327","DOI":"10.1016\/S0021-9258(18)66871-1","article-title":"Human alpha-globin gene expression. The dominant role of the alpha 2-locus in mRNA and protein synthesis","volume":"261","author":"Liebhaber","year":"1986","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI110273","article-title":"Differentiation of the mRNA transcripts originating from the alpha 1- and alpha 2-globin loci in normals and alpha-thalassemics","volume":"68","author":"Liebhaber","year":"1981","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0160","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2002-07-1975","article-title":"Hemoglobin H disease: not necessarily a benign disorder","volume":"101","author":"Chui","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0165","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood.V86.10.3945.bloodjournal86103945","article-title":"The instability of the membrane skeleton in thalassemic red blood cells","volume":"86","author":"Yuan","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.1994.tb01291.x","article-title":"Effect of pyrexia in the formation of intraerythrocytic inclusion bodies and vacuoles in haemolytic crisis of haemoglobin H disease","volume":"52","author":"Chinprasertsuk","year":"1994","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/109065701753145538","article-title":"Universal newborn screening for Hb H disease in California","volume":"5","author":"Lorey","year":"2001","journal-title":"Genet Test"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0180","first-page":"83","article-title":"Gene test review","volume":"13","author":"Galanello","year":"2011","journal-title":"Alpha-thalassemia Genet Med"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13023-020-01429-1","article-title":"Non-deletional alpha thalassaemia: a review","volume":"15","author":"Kalle Kwaifa","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.blre.2023.101165_bb0190","first-page":"329","article-title":"Alpha-thalassemia syndromes: from clinical and molecular diagnosis to bedside management","volume":"7","author":"Viprakasit","year":"2013","journal-title":"Hematology Education"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2006.06423.x","article-title":"Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes","volume":"136","author":"Origa","year":"2007","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJMoa1010174","article-title":"Heterogeneity of hemoglobin H disease in childhood","volume":"364","author":"Lal","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0205","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM200008243430804","article-title":"Genetic and clinical features of hemoglobin H disease in Chinese patients","volume":"343","author":"Chen","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.1142","article-title":"Hemoglobin H (Hb H) disease in Canada: molecular diagnosis and review of 116 cases","volume":"68","author":"Waye","year":"2001","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0215","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2141.2000.02448.x","article-title":"Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience","volume":"111","author":"Kanavakis","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101165_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1196\/annals.1345.003","article-title":"Changing patterns of thalassemia worldwide","volume":"1054","author":"Vichinsky","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2023.101165_bb0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/asheducation-2009.1.26","article-title":"Hb H disease: clinical course and disease modifiers","author":"Fucharoen","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2023.101165_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/TACG.S161152","article-title":"Clinical and molecular genetic features of Hb H and AE Bart\u2019s diseases in central Thai children","volume":"11","author":"Traivaree","year":"2018","journal-title":"Appl Clin Genet"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15568","article-title":"Severity scoring system to guide transfusion management in pediatric non-deletional HbH","volume":"65","author":"Songdej","year":"2023","journal-title":"Pediatr Int"},{"key":"10.1016\/j.blre.2023.101165_bb0240","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2023.283211","article-title":"Quantitative evaluation of the clinical severity of hemoglobin H disease in a cohort of 591 patients using a scoring system based on regression analysis","author":"Liu","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2023.101165_bb0245","series-title":"StatPearls [internet]","article-title":"Hydrops Fetalis","author":"Vanaparthy","year":"2022"},{"key":"10.1016\/j.blre.2023.101165_bb0250","series-title":"Alpha-thalassemia. 2005 Nov 1 [updated 2020 Oct 1]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, bean LJH, Gripp KW, et al., editors. GeneReviews\u00ae [internet]","author":"Tamary","year":"1993"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26056","article-title":"Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later","volume":"96","author":"Musallam","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2023.101165_bb0260","series-title":"2021 Guidelines for the Management of Transfusion-Dependent Thalassemia (TDT)","year":"2021"},{"key":"10.1016\/j.blre.2023.101165_bb0265","series-title":"Guidelines for the Management of non-Transfusion\u2013Dependent Thalassaemia (NTDT)","year":"2017"},{"key":"10.1016\/j.blre.2023.101165_bb0270","series-title":"Guidelines for the Management of non-Transfusion\u2013Dependent \u03b2-Thalassaemia","year":"2023"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0275","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bjh.17203","article-title":"A complication risk score to evaluate clinical severity of thalassaemia syndromes","volume":"192","author":"Vitrano","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101165_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2022.102710","article-title":"Development of a thalassemia international prognostic scoring system (TIPSS)","volume":"99","author":"Vitrano","year":"2023","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0285","first-page":"253","article-title":"The determinants ofconsanguineous marriages among the Arab population: a systematic review","volume":"51","author":"El Goundali","year":"2022","journal-title":"Iran J Public Health"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0290","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/GIM.0b013e318217477f","article-title":"Consanguineous marriages, pearls and perils: Geneva international consanguinity workshop report","volume":"13","author":"Hamamy","year":"2011","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12687-011-0072-y","article-title":"Consanguineous marriages: preconception consultation in primary health care settings","volume":"3","author":"Hamamy","year":"2012","journal-title":"J Community Genet"},{"key":"10.1016\/j.blre.2023.101165_bb0300","author":"Bittles"},{"issue":"20","key":"10.1016\/j.blre.2023.101165_bb0305","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.3390\/ijerph17207354","article-title":"Prevalence of alpha(alpha)-thalassemia in Southeast Asia (2010\u22122020): a meta-analysis involving 83,674 subjects","volume":"17","author":"Goh","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0310","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/ajh.27006","article-title":"Epidemiology of clinically significant forms of alpha- and beta-thalassemia: a global map of evidence and gaps","volume":"98","author":"Musallam","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.hoc.2017.11.008","article-title":"The evolving spectrum of the epidemiology of thalassemia","volume":"32","author":"Weatherall","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0320","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1542\/peds.2005-0843","article-title":"Changes in the epidemiology of thalassemia in North America: a new minority disease","volume":"116","author":"Vichinsky","year":"2005","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0325","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/pbc.21883","article-title":"Newborn screening for hemoglobinopathies in California","volume":"52","author":"Michlitsch","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0330","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/gim.2016.218","article-title":"Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality","volume":"19","author":"He","year":"2017","journal-title":"China Genet Med"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12041-017-0779-6","article-title":"Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy","volume":"96","author":"He","year":"2017","journal-title":"J Genet"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0340","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/03630260701297204","article-title":"Results from the North Cyprus thalassemia prevention program","volume":"31","author":"Bozkurt","year":"2007","journal-title":"Hemoglobin"},{"issue":"22","key":"10.1016\/j.blre.2023.101165_bb0345","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/jpm12040552","article-title":"Global globin network consensus paper: classification and stratified roadmaps for improved thalassaemia care and prevention in 32 countries","volume":"12","author":"Halim-Fikri","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.blre.2023.101165_bb0355","series-title":"Prevention of Thalassaemias and other Haemoglobin disorders: Volume 1: Principles [internet]","article-title":"Newborn screening for haemoglobinopathies","author":"Giordano","year":"2013"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0360","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/ijlh.12037","article-title":"Strategies for basic laboratory diagnostics of the hemoglobinopathies in multi-ethnic societies: interpretation of results and pitfalls","volume":"35","author":"Giordano","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2023.101165_bb0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-62703-029-8_13","article-title":"Newborn screening for hemoglobinopathies using capillary electrophoresis","volume":"919","author":"Giordano","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0370","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1110897","article-title":"Health care systems in low- and middle-income countries","volume":"370","author":"Mills","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32832990a4","article-title":"Ineffective erythropoiesis and thalassemias","volume":"16","author":"Rivella","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb0380","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0268-960X(12)70005-X","article-title":"The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia","volume":"26","author":"Rivella","year":"2012","journal-title":"Blood Rev"},{"issue":"10116","key":"10.1016\/j.blre.2023.101165_bb0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb0390","first-page":"4743","article-title":"Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia","volume":"14","author":"Chansai","year":"2022","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcp\/aqx047","article-title":"Molecular diagnosis of thalassemias and hemoglobinopathies: an ACLPS critical review","volume":"148","author":"Sabath","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0400","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1097\/MPH.0000000000000307","article-title":"Guidelines for the standard monitoring of patients with thalassemia: report of the thalassemia longitudinal cohort","volume":"37","author":"Tubman","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"17","key":"10.1016\/j.blre.2023.101165_bb0405","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2018-06-818187","article-title":"How I manage medical complications of beta-thalassemia in adults","volume":"132","author":"Taher","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0410","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","article-title":"beta-Thalassemias","volume":"384","author":"Taher","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0415","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.20.6.425","article-title":"Phenotype-genotype correlation in haemoglobin H disease in childhood","volume":"20","author":"Galanello","year":"1983","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000204585","article-title":"HbH disease in Sardinia: molecular, hematological and clinical aspects","volume":"88","author":"Galanello","year":"1992","journal-title":"Acta Haematol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb0425","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1182\/blood-2022-167265","article-title":"Clinical burden of alpha- and beta-thalassemia compared to matched controls in thereal-worldsetting","volume":"140","author":"Langer","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0430","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/thalassrep12040020","article-title":"Alpha-thalassemia: diversity of clinical phenotypes and update on the treatment","volume":"12","author":"Songdej","year":"2022","journal-title":"Thalassemia Reports"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0435","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ajh.21523","article-title":"Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications","volume":"84","author":"Singer","year":"2009","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb0440","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00277-021-04456-5","article-title":"Variations in hemoglobin level and morbidity burden in non-transfusion-dependent beta-thalassemia","volume":"100","author":"Musallam","year":"2021","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.blre.2023.101165_bb0445","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000806","article-title":"Untreated anemia in nontransfusion-dependent beta-thalassemia: time to sound the alarm","volume":"6","author":"Musallam","year":"2022","journal-title":"Hemasphere"},{"issue":"10351","key":"10.1016\/j.blre.2023.101165_bb0450","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(22)01337-X","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent \u03b1-thalassaemia or \u03b2-thalassaemia: an open-label, multicentre, phase 2 study","volume":"400","author":"Kuo","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb0455","first-page":"1448","article-title":"Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India","volume":"4","author":"Dhanya","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0460","first-page":"51","article-title":"The regulation of iron absorption and homeostasis","volume":"37","author":"Wallace","year":"2016","journal-title":"Clin Biochem Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb0465","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0268-960X(12)70006-1","article-title":"Iron overload in non-transfusion-dependent thalassemia: a clinical perspective","volume":"26","author":"Musallam","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2023.101165_bb0470","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","author":"Taher","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0475","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0609.1984.tb00694.x","article-title":"Iron overload in patients with haemoglobin H disease","volume":"32","author":"Tso","year":"1984","journal-title":"Scand J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0480","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajh.2830340410","article-title":"Iron overload in Chinese patients with hemoglobin H disease","volume":"34","author":"Hsu","year":"1990","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0485","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.17115","article-title":"Liver complications of haemoglobin H disease in adults","volume":"192","author":"Chan","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2023.101165_bb0490","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221084639","article-title":"Iron overload status in patients with non-transfusion-dependent thalassemia in China","volume":"13","author":"Huang","year":"2022","journal-title":"Ther Adv Hematol"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0495","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00277-009-0701-2","article-title":"Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease","volume":"88","author":"Au","year":"2009","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0500","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3324\/haematol.13098","article-title":"Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia","volume":"93","author":"Taher","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0505","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32835f5a5c","article-title":"Iron overload in beta-thalassemia intermedia: an emerging concern","volume":"20","author":"Musallam","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0510","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.blre.2023.101165_bb0515","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0520","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0525","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2002-09-2754","article-title":"Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool","volume":"101","author":"Jensen","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0530","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3324\/haematol.2013.097220","article-title":"Serum ferritin level and morbidity risk in transfusion-independent patients with beta-thalassemia intermedia: the ORIENT study","volume":"99","author":"Musallam","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0535","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3324\/haematol.2011.047852","article-title":"Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia","volume":"96","author":"Musallam","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0540","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcmd.2013.01.015","article-title":"Evaluation of the 5mg\/g liver iron concentration threshold and its association with morbidity in patients with beta-thalassemia intermedia","volume":"51","author":"Musallam","year":"2013","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0545","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1002\/ajh.26428","article-title":"Risk of mortality from anemia and iron overload in nontransfusion-dependent beta-thalassemia","volume":"97","author":"Musallam","year":"2022","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0550","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ajh.25046","article-title":"A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E\/beta-thalassemia and alpha-thalassemia (Hb H disease)","volume":"93","author":"Ekwattanakit","year":"2018","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0555","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.17839","article-title":"Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias","volume":"196","author":"Shah","year":"2022","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0560","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.mph.0000212910.99394.e0","article-title":"Development of severe anemia during fever episodes in patients with hemoglobin E trait and hemoglobin H disease combinations","volume":"28","author":"Jetsrisuparb","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0565","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/er.2015-1105","article-title":"Bone disease in thalassemia: a molecular and clinical overview","volume":"37","author":"Wong","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.blre.2023.101165_bb0570","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/asheducation-2011.1.443","article-title":"Impact of iron assessment by MRI","author":"Wood","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb0575","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00277-012-1412-7","article-title":"Serum ferritin levels and endocrinopathy in medically treated patients with beta thalassemia major","volume":"91","author":"Belhoul","year":"2012","journal-title":"Ann Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb0580","article-title":"Iron overload: consequences, assessment, and monitoring","volume":"33","author":"Taher","year":"2009","journal-title":"Hemoglobin"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0585","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.080505","article-title":"Bone disease in thalassemia: a frequent and still unresolved problem","volume":"24","author":"Vogiatzi","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0590","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/s41598-017-03029-9","article-title":"Impact of genotype on endocrinal complications of children with alpha-thalassemia in China","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0595","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28109","article-title":"Early development of decreased beta-cell insulin secretion in children and adolescents with hemoglobin H disease and its relationship with levels of anemia","volume":"67","author":"Nakavachara","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0600","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0605","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0610","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajh.26798","article-title":"Overall and complication-free survival in a large cohort of patients with beta-thalassemia major followed over 50 years","volume":"98","author":"Forni","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0615","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00277-018-3493-4","article-title":"National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality","volume":"98","author":"Voskaridou","year":"2019","journal-title":"Ann Hematol"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0620","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.3324\/haematol.2021.278684","article-title":"Survival and causes of death in 2,033 patients with non-transfusion-dependent beta-thalassemia","volume":"106","author":"Musallam","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0625","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000486157","article-title":"Elevations of thrombotic biomarkers in hemoglobin H disease","volume":"139","author":"Chansai","year":"2018","journal-title":"Acta Haematol"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0630","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0635","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2010.03940.x","article-title":"Splenectomy and thrombosis: the case of thalassemia intermedia","volume":"8","author":"Taher","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0640","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hoc.2017.11.001","article-title":"Hypercoagulability and vascular disease","volume":"32","author":"Taher","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0645","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.2000.02376.x","article-title":"Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia","volume":"111","author":"Cappellini","year":"2000","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25502","article-title":"Development of a thalassemia-related thrombosis risk scoring system","volume":"94","author":"Taher","year":"2019","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.blre.2023.101165_bb0655","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2021014862","article-title":"Mortality in beta-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization","volume":"139","author":"Pinto","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0660","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.113.002124","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in a large group of beta-thalassemia patients using right heart catheterization: a Webthal study","volume":"129","author":"Derchi","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0665","first-page":"1335","article-title":"Prevalence and risk factors for cardiac iron overload and cardiovascular complications among patients with thalassemia in northern Thailand","volume":"47","author":"Tantiworawit","year":"2016","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0670","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000347177","article-title":"Pulmonary hypertension risk in patients with hemoglobin H disease: low incidence and absence of correlation with splenectomy","volume":"130","author":"Yin","year":"2013","journal-title":"Acta Haematol"},{"issue":"5B","key":"10.1016\/j.blre.2023.101165_bb0675","first-page":"263","article-title":"Gallstones in thalassemia","volume":"23","author":"Chandrcharoensin-Wilde","year":"1988","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0680","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00277-005-1091-8","article-title":"Hyperbilirubinemia and cholelithiasis in Chinese patients with hemoglobin H disease","volume":"84","author":"Au","year":"2005","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0685","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2133.1978.tb01629.x","article-title":"Leg ulcers in alpha-thalassaemia (haemoglobin H disease)","volume":"98","author":"Daneshmend","year":"1978","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0690","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajh.2830410412","article-title":"Intrathoracic extramedullary hematopoietic tumor in hemoglobin H disease","volume":"41","author":"Wu","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2023.101165_bb0695","first-page":"4504302","article-title":"Erythropoiesis and iron homeostasis in non-transfusion-dependent thalassemia patients with extramedullary hematopoiesis","volume":"2019","author":"Huang","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.blre.2023.101165_bb0700","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/793025","article-title":"Prevalence and risk factors for complications in patients with nontransfusion dependent alpha- and beta-thalassemia","volume":"2015","author":"Winichakoon","year":"2015","journal-title":"Anemia"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0705","first-page":"538","article-title":"Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study","volume":"14","author":"Ricchi","year":"2016","journal-title":"Blood Transfus"},{"key":"10.1016\/j.blre.2023.101165_bb0710","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/271070","article-title":"Clinical features and molecular analysis of Hb H disease in Taiwan","volume":"2014","author":"Chao","year":"2014","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0715","first-page":"339","article-title":"Alpha and beta thalassemia","volume":"80","author":"Muncie","year":"2009","journal-title":"Am Fam Physician"},{"issue":"8653","key":"10.1016\/j.blre.2023.101165_bb0720","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"2","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2023.101165_bb0725","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1196\/annals.1345.006","article-title":"Survival and complications in thalassemia","volume":"1054","author":"Borgna-Pignatti","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0730","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijns5010016","article-title":"Thalassemias: an overview","volume":"5","author":"Angastiniotis","year":"2019","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0735","first-page":"107","article-title":"Outcomes and morbidities of patients who survive haemoglobin Bart\u2019s hydrops fetalis syndrome: 20-year retrospective review","volume":"24","author":"Chan","year":"2018","journal-title":"Hong Kong Med J"},{"issue":"5 Pt 1","key":"10.1016\/j.blre.2023.101165_bb0740","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3476(86)81048-4","article-title":"Survival of a hydropic infant with homozygous alpha-thalassemia-1","volume":"108","author":"Beaudry","year":"1986","journal-title":"J Pediatr"},{"issue":"5 Pt 1","key":"10.1016\/j.blre.2023.101165_bb0745","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0022-3476(86)81049-6","article-title":"Normal long-term survival with alpha-thalassemia","volume":"108","author":"Bianchi","year":"1986","journal-title":"J Pediatr"},{"issue":"7\u20138","key":"10.1016\/j.blre.2023.101165_bb0750","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1754.2007.01131.x","article-title":"Outcome of intensive care of homozygous alpha-thalassaemia without prior intra-uterine therapy","volume":"43","author":"Lee","year":"2007","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0755","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jpeds.2008.11.031","article-title":"Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation","volume":"154","author":"Yi","year":"2009","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0760","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/(SICI)1097-0223(199808)18:8<838::AID-PD341>3.0.CO;2-#","article-title":"In utero exchange transfusion in homozygous alpha-thalassaemia: a case report","volume":"18","author":"Fung","year":"1998","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0765","first-page":"951","article-title":"Health-related quality of life in Thai thalassemic children treated with iron chelation","volume":"42","author":"Torcharus","year":"2011","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0770","doi-asserted-by":"crossref","first-page":"xv","DOI":"10.1016\/j.hoc.2017.12.003","article-title":"Thalassemia","volume":"32","author":"Taher","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0775","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12913-022-07663-6","article-title":"Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study","volume":"22","author":"Alshamsi","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb0780","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2022-167125","article-title":"Characterizing the clinical, health-related quality of life and economic burden of alpha-thalassemia: a systematic literature review and evidence gaps assessment","volume":"140","author":"Musallam","year":"2022","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb0785","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0268-960X(12)70010-3","article-title":"Advances in the treatment of alpha-thalassemia","volume":"26","author":"Vichinsky","year":"2012","journal-title":"Blood Rev"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb0790","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1111\/trf.16636","article-title":"Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: a real-world analysis","volume":"61","author":"Tang","year":"2021","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0795","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2019.12.003","article-title":"Systematic literature review of the burden of disease and treatment for transfusion-dependent beta-thalassemia","volume":"42","author":"Betts","year":"2020","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0800","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2141.1966.tb00125.x","article-title":"Persistent post-splenectomy thrombocytosis and thrombo-embolism: a consequence of continuing anaemia","volume":"12","author":"Hirsh","year":"1966","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0805","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1445-5994.1982.tb02655.x","article-title":"Venous thrombosis in haemoglobin H disease after splenectomy","volume":"12","author":"Tso","year":"1982","journal-title":"Aust N Z J Med"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0810","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00277-008-0556-y","article-title":"Erythropoietin for hemoglobin H disease","volume":"88","author":"Fortenko","year":"2009","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0815","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2011.08617.x","article-title":"Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes","volume":"154","author":"Singer","year":"2011","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0820","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2010-11-316646","article-title":"Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years\u2019 follow-up","volume":"118","author":"Cappellini","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0825","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.V95.4.1229.004k32_1229_1236","article-title":"Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia","volume":"95","author":"Davis","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0830","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ajh.24668","article-title":"New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: results of the randomized, phase II ECLIPSE study","volume":"92","author":"Taher","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0835","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.23876","article-title":"Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine","volume":"90","author":"Pennell","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0840","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.2011.049957","article-title":"Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with beta-thalassemia major","volume":"97","author":"Pennell","year":"2012","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.blre.2023.101165_bb0845","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(20)30100-9","article-title":"Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial","volume":"7","author":"Maggio","year":"2020","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0855","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0860","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.2006.05984.x","article-title":"Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease","volume":"133","author":"Chan","year":"2006","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0865","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood-2012-02-412692","article-title":"Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study","volume":"120","author":"Taher","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0870","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00277-013-1808-z","article-title":"Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study","volume":"92","author":"Taher","year":"2013","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0875","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ajh.23445","article-title":"Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients","volume":"88","author":"Taher","year":"2013","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.blre.2023.101165_bb0880","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26592","article-title":"An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results","volume":"97","author":"Lai","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2023.101165_bb0885","series-title":"package insert","author":"JADENU\u00ae (deferasirox)","year":"2020"},{"key":"10.1016\/j.blre.2023.101165_bb0890","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/asheducation-2010.1.456","article-title":"Hematopoietic stem cell transplantation in thalassemia","author":"Angelucci","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb0895","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hoc.2022.12.009","article-title":"Hematopoietic stem cell transplantation in thalassemia","volume":"37","author":"Algeri","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0900","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms18112472","article-title":"Is the benefit-risk ratio for patients with transfusion-dependent thalassemia treated by unrelated cord blood transplantation favorable?","volume":"18","author":"Jaing","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb0905","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbmt.2011.01.012","article-title":"Umbilical cord blood transplantation for children with thalassemia and sickle cell disease","volume":"17","author":"Ruggeri","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2023.101165_bb0910","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1196\/annals.1345.023","article-title":"Unrelated bone marrow transplantation for beta-thalassemia patients: the experience of the Italian bone marrow transplant group","volume":"1054","author":"La Nasa","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"17","key":"10.1016\/j.blre.2023.101165_bb0915","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/bloodadvances.2019000291","article-title":"Related and unrelated donor transplantation for \u03b2-thalassemia major: results of an international survey","volume":"3","author":"Li","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2023.101165_bb0920","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/hematology.2021000295","article-title":"Advances in the management of \u03b1-thalassemia major: reasons to be optimistic","author":"Horvei","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0925","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0022-3476(98)70406-8","article-title":"Treatment of hemoglobin Bart\u2019s hydrops with bone marrow transplantation","volume":"132","author":"Chik","year":"1998","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0930","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1703104","article-title":"Successful mismatched sibling cord blood transplant in Hb Bart\u2019s disease","volume":"28","author":"Zhou","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0935","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.bmt.1704129","article-title":"Homozygous alpha-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation","volume":"32","author":"Thornley","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb0940","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3121\/cmr.2.4.228","article-title":"Hydrops fetalis caused by homozygous alpha-thalassemia and Rh antigen alloimmunization: report of a survivor and literature review","volume":"2","author":"Joshi","year":"2004","journal-title":"Clin Med Res"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb0945","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/MPH.0b013e31827e7f6a","article-title":"Successful unrelated cord blood transplantation for homozygous alpha-thalassemia","volume":"35","author":"Gumuscu","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0950","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/bmt.2013.131","article-title":"Normal cognitive functioning in a patient with Hb Bart\u2019s hydrops successfully cured by hematopoietic SCT","volume":"49","author":"Pongtanakul","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb0955","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/bmt.2016.153","article-title":"Successful matched unrelated donor stem cell transplant in hemoglobin Bart\u2019s disease","volume":"51","author":"Elsaid","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0960","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/pbc.26163","article-title":"Homozygous alpha-thalassemia: challenges surrounding early identification, treatment, and cure","volume":"64","author":"Pecker","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"13","key":"10.1016\/j.blre.2023.101165_bb0965","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/pd.4966","article-title":"Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature","volume":"36","author":"Kreger","year":"2016","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.blre.2023.101165_bb0970","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14037","article-title":"Outcomes of allogeneic transplantation for hemoglobin Bart\u2019s hydrops fetalis syndrome in Hong Kong","volume":"25","author":"Chan","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0975","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/03630269.2015.1105815","article-title":"Curative stem cell transplantation for severe Hb H disease manifesting from early infancy: phenotypic and genotypic analyses","volume":"40","author":"Surapolchai","year":"2016","journal-title":"Hemoglobin"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0980","doi-asserted-by":"crossref","first-page":"e1426","DOI":"10.1542\/peds.2007-1944","article-title":"Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthood","volume":"121","author":"Musallam","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb0985","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajh.21398","article-title":"The influence of treatment in specialized centers on survival of patients with thalassemia major","volume":"84","author":"Forni","year":"2009","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb0990","first-page":"CD002890","article-title":"Psychological therapies for thalassaemia","volume":"2014","author":"Anie","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb0995","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12884-022-04660-9","article-title":"A decade of molecular preimplantation genetic diagnosis of 350 blastomeres for beta-thalassemia combined with HLA typing, aneuploidy screening and sex selection in Iran","volume":"22","author":"Keshvar","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"20","key":"10.1016\/j.blre.2023.101165_bb1000","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMra1404415","article-title":"The alpha-thalassemias","volume":"371","author":"Piel","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2023.101165_bb1005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/asheducation-2009.1.35","article-title":"Alpha thalassemia major--new mutations, intrauterine management, and outcomes","author":"Vichinsky","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2023.101165_bb1010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2016.10.014","article-title":"Prenatal ultrasound monitoring of homozygous \u03b1(0)-thalassemia-induced fetal anemia","volume":"39","author":"Lee","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.blre.2023.101165_bb1015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejogrb.2020.08.001","article-title":"Non-invasive prenatal diagnosis and screening for monogenic disorders","volume":"253","author":"Scotchman","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb1020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004310051053","article-title":"Homozygous alpha-thalassaemia and hypospadias\u2014common aetiology or incidental association? Long-term survival of Hb Bart\u2019s hydrops syndrome leads to new aspects for counselling of alpha-thalassaemic traits","volume":"158","author":"Dame","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb1025","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V91.7.2213","article-title":"Hydrops fetalis caused by \u03b1-thalassemia: an emerging health care problem","volume":"91","author":"Chui","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2023.101165_bb1030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1471-0528.1985.tb01447.x","article-title":"Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases","volume":"92","author":"Liang","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb1035","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000446","article-title":"Recommendations for pregnancy in rare inherited anemias","volume":"4","author":"Taher","year":"2020","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb1040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.siny.2008.02.006","article-title":"Alpha-thalassaemia","volume":"13","author":"Leung","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3 Pt 1","key":"10.1016\/j.blre.2023.101165_bb1045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1479-828X.1989.tb01726.x","article-title":"Bart\u2019s hydrops fetalis\u2014clinical presentation and management--an analysis of 25 cases","volume":"29","author":"Tan","year":"1989","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.blre.2023.101165_bb1050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0002-9378(85)90461-2","article-title":"alpha-thalassemia hydrops fetalis: clinical and ultrasonographic considerations","volume":"153","author":"Guy","year":"1985","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.blre.2023.101165_bb1055","first-page":"125","article-title":"Hemoglobin barts hydrops fetalis syndrome","volume":"20","author":"Bowman","year":"1987","journal-title":"Haematologia (Budap)"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2023.101165_bb1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2020-142698","article-title":"In utero stem cell transplantation in patients with alpha thalassemia major: interim results of a phase 1 clinical trial","volume":"136","author":"MacKenzie","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2023.101165_bb1065","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood-2016-11-753525","article-title":"AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency","volume":"130","author":"Kung","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2023.101165_bb1070","first-page":"2535","article-title":"Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in beta-thalassemic mice","volume":"108","author":"Matte","year":"2023","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb1075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144206","article-title":"The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a beta-thalassemia mouse model","volume":"131","author":"Matte","year":"2021","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb1080","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","article-title":"Hepcidin in iron overload disorders","volume":"105","author":"Papanikolaou","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb1085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2018-07-815928","article-title":"Iron metabolism under conditions of ineffective erythropoiesis in beta-thalassemia","volume":"133","author":"Rivella","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2023.101165_bb1090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2023.101165_bb1095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjh.17428","article-title":"SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of \u03b2-thalassaemia","volume":"194","author":"Vadolas","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2023.101165_bb1100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.blre.2023.101165_bb1105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent beta-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.blre.2023.101165_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(22)00208-3","article-title":"Luspatercept for the treatment of anaemia in non-transfusion-dependent beta-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial","volume":"9","author":"Taher","year":"2022","journal-title":"Lancet Haematol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X23001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X23001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:31:04Z","timestamp":1759437064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X23001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":222,"alternative-id":["S0268960X23001352"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2023.101165","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0391lpha-thalassemia: A practical overview","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2023.101165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101165"}}